Literature DB >> 30105381

Efficacy of an Empowerment-Based, Group-Delivered HIV Prevention Intervention for Young Transgender Women: The Project LifeSkills Randomized Clinical Trial.

Robert Garofalo1,2, Lisa M Kuhns1,2, Sari L Reisner3,4,5, Katie Biello5,6,7,8, Matthew J Mimiaga5,6,7,8,9.   

Abstract

Importance: The incidence of HIV infection among transgender women in the United States is extremely high, with young transgender women (YTW) at highest risk; condomless sex is the primary risk behavior for transmission. However, there are no published randomized clinical trials to date examining interventions to reduce sexual risk for HIV acquisition and transmission within this group. Objective: To determine the efficacy of a culturally specific, empowerment-based, and group-delivered behavioral prevention intervention to reduce sexual risk for HIV acquisition and transmission in sexually active YTW aged 16 to 29 years. Design, Setting, and Participants: Randomized clinical efficacy trial of Project LifeSkills, a group-delivered, behavioral HIV prevention intervention, vs standard of care conducted among 190 sexually active YTW between March 26, 2012, and August 15, 2016, at community-based locations in Boston, Massachusetts, and Chicago, Illinois, to reduce sexual risk for HIV acquisition or transmission. Data analysis was by a modified intention-to-treat approach. Interventions: Participants were randomized (approximately 2:2:1) to the LifeSkills intervention (n = 116), standard of care only (n = 74), or a diet and nutrition time- and attention-matched control (attention control) arm (n = 43). The attention control arm was dropped during active enrollment per the Data Safety and Monitoring Board's recommendation. The LifeSkills intervention was delivered in six 2-hour sessions spanning a 3-week period. Main Outcomes and Measures: Primary outcome was change in the number of self-reported condomless anal or vaginal sex acts in the 4 months before the baseline assessment and that reported at the 4-, 8-, and 12-month visits.
Results: Of the 190 study participants, the mean (SD) age was 23.4 (3.4) years (range, 16-29 years); 47 (24.7%) were white, 83 (43.7%) were black or African American, 25 (13.2%) were Hispanic or Latina, and 35 (18.4%) were another race/ethnicity. From baseline to 4 months, the LifeSkills group had a 30.8% greater mean (SE) reduction in condomless sex acts (2.26 [0.40] at baseline vs 1.22 [0.22] at 4 months) compared with the standard of care group (2.69 [0.59] at baseline vs 2.10 [0.47] at 4 months) (risk ratio [RR], 0.69; 95% CI, 0.60-0.80; P < .001). Similarly, the LifeSkills group had a 39.8% greater mean (SE) reduction in condomless sex acts at the 12-month follow-up visit compared with the standard of care group (0.71 [0.13] vs 1.40 [0.32]; RR, 0.60; 95% CI, 0.50-0.72; P < .001). Conclusions and Relevance: Among YTW at sexual risk of HIV acquisition or transmission, the LifeSkills intervention resulted in a 39.8% greater mean reduction in condomless sex acts during the 12-month follow-up in comparison to the standard of care group. This trial is the first to date to demonstrate evidence of efficacy for a behavioral intervention to reduce sexual risk in YTW. Trial Registration: ClinicalTrials.gov Identifier: NCT01575938.

Entities:  

Mesh:

Year:  2018        PMID: 30105381      PMCID: PMC6233762          DOI: 10.1001/jamapediatrics.2018.1799

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  21 in total

1.  Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium.

Authors:  Albert J Bellg; Belinda Borrelli; Barbara Resnick; Jacki Hecht; Daryl Sharp Minicucci; Marcia Ory; Gbenga Ogedegbe; Denise Orwig; Denise Ernst; Susan Czajkowski
Journal:  Health Psychol       Date:  2004-09       Impact factor: 4.267

2.  HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.

Authors:  Susan P Buchbinder; David V Glidden; Albert Y Liu; Vanessa McMahan; Juan V Guanira; Kenneth H Mayer; Pedro Goicochea; Robert M Grant
Journal:  Lancet Infect Dis       Date:  2014-03-07       Impact factor: 25.071

3.  Understanding AIDS-risk behavior among adolescents in psychiatric care: links to psychopathology and peer relationships.

Authors:  G R Donenberg; E Emerson; F B Bryant; H Wilson; E Weber-Shifrin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-06       Impact factor: 8.829

4.  Diagnosed HIV Infection in Transgender Adults and Adolescents: Results from the National HIV Surveillance System, 2009-2014.

Authors:  Hollie Clark; Aruna Surendera Babu; Ellen Weiss Wiewel; Jenevieve Opoku; Nicole Crepaz
Journal:  AIDS Behav       Date:  2017-09

5.  Life skills: evaluation of a theory-driven behavioral HIV prevention intervention for young transgender women.

Authors:  Robert Garofalo; Amy K Johnson; Lisa M Kuhns; Christopher Cotten; Heather Joseph; Andrew Margolis
Journal:  J Urban Health       Date:  2012-06       Impact factor: 3.671

6.  Correlates of PrEP Indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender Women.

Authors:  Lisa M Kuhns; Sari L Reisner; Matthew J Mimiaga; Travis Gayles; Michael Shelendich; Robert Garofalo
Journal:  AIDS Behav       Date:  2016-07

Review 7.  Worldwide burden of HIV in transgender women: a systematic review and meta-analysis.

Authors:  Stefan D Baral; Tonia Poteat; Susanne Strömdahl; Andrea L Wirtz; Thomas E Guadamuz; Chris Beyrer
Journal:  Lancet Infect Dis       Date:  2012-12-21       Impact factor: 25.071

8.  Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States.

Authors:  Catherine A Koss; Sybil G Hosek; Peter Bacchetti; Peter L Anderson; Albert Y Liu; Howard Horng; Leslie Z Benet; Karen Kuncze; Alexander Louie; Parya Saberi; Craig M Wilson; Monica Gandhi
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

9.  Rapid HIV testing in transgender communities by community-based organizations in three cities.

Authors:  Jeffrey D Schulden; Binwei Song; Alex Barros; Azul Mares-DelGrasso; Charles W Martin; Ramon Ramirez; Linney C Smith; Darrell P Wheeler; Alexandra M Oster; Patrick S Sullivan; James D Heffelfinger
Journal:  Public Health Rep       Date:  2008 Nov-Dec       Impact factor: 2.792

10.  The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention.

Authors:  Carlos F Cáceres; Florence Koechlin; Pedro Goicochea; Papa-Salif Sow; Kevin R O'Reilly; Kenneth H Mayer; Peter Godfrey-Faussett
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

View more
  15 in total

1.  Urgent Need for Research to Achieve Health Equity for Sexual and Gender Minority Youth.

Authors:  Nadia Dowshen; Carol A Ford
Journal:  Pediatrics       Date:  2019-08-19       Impact factor: 7.124

2.  Longitudinal Analysis of Syndemic Psychosocial Problems Predicting HIV Risk Behavior Among a Multicity Prospective Cohort of Sexually Active Young Transgender Women in the United States.

Authors:  Matthew J Mimiaga; Jaclyn M W Hughto; Katie B Biello; Christopher M Santostefano; Lisa M Kuhns; Sari L Reisner; Robert Garofalo
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

3.  Prospective relationships between stigma, mental health, and resilience in a multi-city cohort of transgender and nonbinary individuals in the United States, 2016-2019.

Authors:  Pablo K Valente; Jordan D Dworkin; Curtis Dolezal; Anneliese A Singh; Allen J LeBlanc; Walter O Bockting
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-03-21       Impact factor: 4.328

Review 4.  HIV Prevention Interventions for Adolescents.

Authors:  Sybil Hosek; Audrey Pettifor
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

Review 5.  Optimizing HIV prevention and care for transgender adults.

Authors:  Jordan E Lake; Jesse L Clark
Journal:  AIDS       Date:  2019-03-01       Impact factor: 4.177

6.  Social Capital Moderates the Relationship Between Stigma and Sexual Risk Among Male Sex Workers in the US Northeast.

Authors:  Pablo K Valente; Matthew J Mimiaga; Kenneth H Mayer; Steve A Safren; Katie B Biello
Journal:  AIDS Behav       Date:  2020-01

7.  Maternal Support Is Protective Against Suicidal Ideation Among a Diverse Cohort of Young Transgender Women.

Authors:  Harry Jin; Arjee Restar; William C Goedel; Adedotun Ogunbajo; Katie Biello; Don Operario; Lisa Kuhns; Sari L Reisner; Robert Garofalo; Matthew J Mimiaga
Journal:  LGBT Health       Date:  2020-09-04       Impact factor: 4.151

8.  Eliciting critical hope in community-based HIV research with transgender women in Toronto, Canada: methodological insights.

Authors:  Carmen H Logie; David J Kinitz; Lesley Gittings; Yasmeen Persad; Ashley Lacombe-Duncan; Tonia Poteat
Journal:  Health Promot Int       Date:  2022-06-23       Impact factor: 3.734

9.  "You talk about problems until you feel free": South African adolescent girls' and young women's narratives on the value of HIV prevention peer support clubs.

Authors:  Deborah Baron; Fiona Scorgie; Lethabo Ramskin; Nomhle Khoza; Jennifer Schutzman; Anne Stangl; Sheila Harvey; Sinead Delany-Moretlwe
Journal:  BMC Public Health       Date:  2020-06-26       Impact factor: 3.295

10.  Evaluating Locally Developed Interventions to Promote PrEP Among Racially/Ethnically Diverse Transgender Women in the United States: A Unique CDC Initiative.

Authors:  Scott D Rhodes; Lisa M Kuhns; Jasmine Alexander; Jorge Alonzo; Patricia A Bessler; Cari Courtenay-Quirk; Damian J Denson; Kaiji Evans; Carla A Galindo; Robert Garofalo; Deborah J Gelaude; Anna L Hotton; Amy K Johnson; Lilli Mann-Jackson; Abigail Muldoon; Reyna Ortiz; Josie Lynne Paul; Judy Perloff; Kevin Pleasant; Beth A Reboussin; Lucero Refugio Aviles; Eunyoung Y Song; Amanda E Tanner; Scott Trent
Journal:  AIDS Educ Prev       Date:  2021-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.